What is divvyDOSE?
divvyDOSE operates at the intersection of health-tech and pharmaceutical logistics, providing a sophisticated platform for medication adherence. By organizing complex prescription regimens, over-the-counter medications, and daily supplements into intuitive, time-stamped packs, the company addresses the critical issue of medication non-compliance. Their service model, which includes automated refills and direct-to-door shipping, is supported by a 24/7 pharmacy infrastructure. This approach not only simplifies the patient experience but also fosters collaborative care by integrating prescriber reviews into the medication planning process, ensuring that safety and efficacy remain at the forefront of their service delivery.
How much funding has divvyDOSE raised?
divvyDOSE has raised a total of $2M across 1 funding round:
Debt
$2M
Debt (2020): $2M with participation from PPP
Key Investors in divvyDOSE
PPP
Public-Private Partnership
What's next for divvyDOSE?
The infusion of capital positions divvyDOSE to scale its enterprise-level operations, likely focusing on expanding its reach within the chronic care management market. As the company transitions into its next phase of growth, strategic priorities will likely include enhancing its proprietary pharmacy automation technology and deepening integrations with healthcare providers. By leveraging this recent financing, divvyDOSE is well-equipped to navigate the complexities of the modern healthcare landscape, aiming to reduce systemic inefficiencies while improving long-term health outcomes for patients with multi-medication requirements.
See full divvyDOSE company page
